had ik maar schreef op 13 februari 2013 01:08:
[...]
Patient, ik volg je redenering, echter,
ben je niet bang dat Octoplus (Dhr. Egberts en the board ..) het op noodweer of overmacht zal gooien, dit ten voordele voor het voortbestaan van het bedrijf, de werkgelegenheid en de aandeelhouders? Ze hebben zich immers zéér goed ingedekt, onder andere.........
In het Position Statement van 13/12/2012 (
www.octoplus.nl/files/2513/5543/4788/... ) sectie - EXPLANATORY NOTES TO THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF OCTOPLUS N.V. TO BE HELD ON 15 JANUARY 2013 blz.25:
Item 2. Explanation of measures taken in respect of decrease of OctoPlus’ equity in accordance with section 2:108a of the Dutch Civil Code (non voting item)
As a consequence of the impairment loss in 2012 in relation to Biolex Therapeutics Inc.’s voluntary petition for liquidation under Chapter 7 (see OctoPlus’ press release dated 9 July 2012), OctoPlus’ equity has decreased and following continuing losses over the last months, OctoPlus’ current equity is below the level of half of its issued and paid-up share capital. Therefore, in accordance with section 2:108a of the Dutch Civil Code, OctoPlus wants to discuss any appropriate measures it has taken in this respect. As a long-term measure the Executive Board reviewed various strategic alternatives for the Company. After careful consideration the Executive Board and the Supervisory Board decided to pursue an acquisition by a strategic partner which ultimately resulted in indicative offers from two strategic partners of which ultimately the intended public offer by Dr. Reddy’s was selected.